ExecPay

Mutya Harsch

Overview202220212020

Overview

Mutya Harsch received an average of $958K in total compensation, including $382K in salary, at VYNE Therapeutics from 2020 to 2022.

Source: SEC filings on November 13, 2023, June 17, 2022, and June 7, 2021.
Harsch's 2022 pay

Related executives

We found seven more executives who work or worked at VYNE Therapeutics.

David Domzalski

VYNE Therapeutics

Chief Executive Officer

3

Iain Stuart

VYNE Therapeutics

Chief Scientific Officer

2

Steven Basta

VYNE Therapeutics

Chief Executive Officer

4

Andrew Saik

VYNE Therapeutics

Chief Financial Officer

1

Kristine Ball

VYNE Therapeutics

Chief Financial Officer

3

Paul Kwon

VYNE Therapeutics

Chief Scientific Officer

1

Mary Spellman

VYNE Therapeutics

Chief Medical Officer

2

News

You may also like

VYNE Therapeutics